Genesis HealthCare — Cyborg Score 7/10

Strong
Skilled nursing facilities and post-acute care services

Strategic Profile

The company focuses on the medical and physical issues facing elderly patients and is provided by the employees of skilled nursing facilities, assisted/senior living communities, integrated and third-party rehabilitation therapy business. Genesis also supplies rehabilitation therapy to approximately 1,700 healthcare providers in 45 states and the District of Columbia. The company maintains a diversified revenue model anchored in skilled nursing operations with meaningful margin contributions from therapy services.

Cyborg Score Rationale

Genesis operates an extensive, geographically diverse network of high-margin skilled nursing facilities with contracted rehabilitation services generating recurring revenue. The company has a market cap of $15.58B and net margin of 19.46% (ttm). Primary risks include regulatory pressure on reimbursement rates and labor cost inflation in post-acute care.

Top Insights

  • Genesis Healthcare reports an annual revenue of approximately 3.6 billion USD with a workforce of about 30,000 employees. This scale provides operational leverage but also exposes the company to labor cost pressures typical in healthcare services.
  • As of November 2023, Genesis owned or operated 290 skilled nursing facilities with 34,047 beds through 105 affiliates in 25 states. The property-light affiliate model provides capital efficiency while maintaining operational control.
  • Genesis carries a forward P/E of 8.93 and a dividend yield of 1.90% (as of May 2026). Attractive valuation relative to historical levels suggests investor confidence in post-acute care sector normalization.

Named Competitors

  • Amedisys — Home health and hospice services
  • Encompass Health — Inpatient rehabilitation facility services
  • Kindred Healthcare — Skilled nursing and rehabilitation services
  • Brookdale Senior Living — Senior living and assisted living communities

Recent Developments

  • (May 2026) Ex-dividend date of May 18, 2026 for $0.50 per share dividend payment

Open the full interactive Genesis HealthCare report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.

Open report →